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Background: 33,4 Million people were living with the Human Immune Deficiency 
virus by the end of 2009 with sub-Saharan Africa the most affected region. Maternal 
HIV infection is the leading cause of maternal and child morbidity and mortality in 
South Africa. A meta-analysis of world literature suggests a clear association 
between HIV infection and perinatal mortality.   
 Aims and Objectives: 
To study the effect of HIV status on perinatal outcome at Mowbray Maternity 
Hospital(a secondary level hospital in Cape Town, South Africa.) and its catchment 
MOUs. 
Specific aims: 
1) To compare the perinatal mortality rate in the group of HIV exposed with 
the HIV negative group and the untested group. 
2) To determine where possible, the primary obstetric cause of adverse 
outcome and compare this in HIV exposed  to the HIV negative and the 
untested group. 
3) To compare the incidence of Neonatal Encephalopathy in the group of HIV 
exposed with the HIV negative group and the untested group.  
 
 
Methods: The study was a retrospective descriptive and comparative audit. All 
deliveries at MMH and its referral midwife obstetric units from January 2008 to 
December 2008 were audited with respect to HIV status and other demographic 
data. All deliveries with perinatal mortality and or neonatal encephalopathy were 
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Results: There was a total of 18 870 deliveries at the units being studied. The 
number of deliveries to HIV positive mothers were 3259 (17,2 %). The stillbirth rate 
in the HIV positive population for the units being studied was 17,1 per 1000 
deliveries. In the HIV negative population this rate was 8,3 per 1000 deliveries. The 
odds ratio was 2,07 [CI, 1.5-2.8] with a p-value of <0,0001. The neonatal death rate 
in the HIV positive population was 4,6 per 1000 deliveries, this as opposed to a rate 
of 3,1 per 1000 in the HIV negative population. The odds ratio was calculated as 
1,46 [ CI, 0.8-2.6] with a p-value of 0,26. The perinatal mortality rate in the HIV 
population was 21,7 per 1000 deliveries. In the HIV negative population this rate 
was 11,7 per 1000 deliveries. The odds ratio was 1,91 [CI, 1.4-2.5] with a p-value of 
<0,0001. A comparison of the pattern of primary obstetric cause for perinatal 
mortality showed that infection, intra uterine growth restriction and ante partum 
haemorrhage were significantly more common as a cause for perinatal death in the 
HIV positive population. The risk of neonatal encephalopathy in the HIV exposed 
population was 4,9 per 1000 deliveries as opposed to 2,07 per 1000 deliveries in the 
HIV negative group. Comparing the two groups found an odds ratio of 2,36 [CI, 1.28-
4.35] with the p-value 0,008.  
The untested group of patients is shown in this study to be at particularly high risk 
of adverse perinatal outcome. This consists mostly of mothers who have had no 
antenatal care in the index pregnancy. 
Discussion: The perinatal mortality rate in the group of HIV exposed mothers was 
significantly higher than the HIV negative group due to a higher stillbirth rate. The 
lack of difference in neonatal death rate could be due to the high standard of 
neonatal care at the hospital. There was no significant difference in demographic 
data between the HIV positive and negative groups.        
Conclusion: Parturients who were infected with HIV were at significantly increased 
risk of perinatal mortality. Infection, intra uterine growth restriction and 
antepartum haemorrhage were significantly more common obstetric causes for 
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infected population. The risk of neonatal encephalopathy was also significantly 
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The Millennium Declaration by the United Nations general assembly was signed on 
18 September 2000. This gathering took place in New York at the United Nations 
millennium summit and was the largest ever gathering of heads of state. There 
were 8 goals set out in this document with an undertaking by 198 heads of state to 
attempt achieving these goals by 2015. The 8 goals in the section on development 
and poverty eradication are known as the millennium development goals. 
Goal 4 of the declaration reads as follows: “REDUCE CHILD MORTALITY”. One of the 
targets specified in achieving this goal is to reduce by two thirds between 1990 and 
2015 the younger than five year child mortality rate.  
According to World Health Organisation figures an estimated 4 million pregnancies 
end with a stillbirth annually worldwide. 1 98 % of these are from developing 
countries.2 This figure is considered a gross underestimation as a large number of 
deliveries are performed outside of healthcare facilities and are thus either not 
reported or captured in official statistics.3,4 As a consequence studying 
epidemiology and causes of perinatal mortality in developing countries is complex. 
In sub-Saharan Africa it is estimated that stillbirths account for more than 3 % of all 
births.2 
A multitude of factors lead to the high rate of perinatal mortality in developing 
countries. Several studies have suggested that exposure to the Human 
Immunodeficiency virus in utero poses an independent risk factor for adverse 
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South Africa has the largest population of people living with HIV in the world, the 
UNAIDS report in 2008 states this to be 5,7 million people with a prevalence of 
20.9%. 6 The association between HIV status and perinatal mortality in the Peninsula 
Maternal and Neonatal Service (PMNS), Cape Town is the subject of this study. In 
Cape Town (South Africa), the Western Cape Department of Health has adequate 
infrastructure in place and record keeping in the PMNS for HIV status and perinatal 
mortality is of good standard. This situation in combination with the fact that the 
population being serviced by the public health facilities is one living in a developing 
country, thus faced by the same risks for adverse pregnancy outcome as parturients 
in other developing countries, makes it an ideal situation for study. At Mowbray 
Maternity Hospital during 2006 the perinatal mortality rate was recorded as 29,4 
per 1000 deliveries. At the MOUs the perinatal mortality rate was 15,8 per 1000 
deliveries.       
 
LITERATURE REVIEW. 
By the end of 2009 about 33,4 million people worldwide were living with the 
Human Immune Deficiency virus (HIV). Sub-Saharan Africa is the most affected area 
in the world in this regard with 67 % of the world’s population living with HIV 
residing in this region.6 This is a staggering 22,4 million people. The number of 
newly infected children in sub-Saharan Africa in 2008 was estimated at 390 000. 
This 2009 UNAIDS update on the AIDS epidemic again comments on the 
disproportionate impact of HIV on women and girls. In Cote d’Ivoire HIV prevalence 
among females were twice as high as in their male counterparts. The reason for this 
is multi factorial. Due to physiological factors women are at increased risk of 
contracting the virus. In addition to this physiological susceptibility to heterosexual 
transmission of the virus, women in sub-Saharan Africa are also faced with social 
and economic disadvantages that increase their risk of contracting HIV even further.   
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Maternal Human Immune Deficiency virus infection is the leading  underlying cause 
of maternal and infant death in South Africa. 7,8 
HIV prevalence in pregnancy is especially high in Southern Africa, with the 
prevalence in pregnant women attending antenatal clinic in Uganda, South Africa 
and Botswana during 2003-2004 ranging from 6 to 39%.9 
Annual routine statistics show that the prevalence of HIV infection among pregnant 
mothers delivering at Mowbray Maternity Hospital during 2008 was 19%. 
A review of world literature suggests a clear association between HIV infection and 
stillbirth. A meta-analysis of 31 trials reported a fourfold increase in stillbirths if a 
group of mothers infected with the Human Immune Deficiency Virus is compared to 
a similar group of mothers testing negative for the Human Immune deficiency 
Virus.10 
In spite of a steady decline in perinatal mortality in first world countries, it is feared 
that the Human Immune Deficiency Virus epidemic will negate any progress made 
with regards to this in developing countries. This point is illustrated by a registry 
based study done in Tanzania analysing 14 444 singleton deliveries. The association 
between maternal Human Immune deficiency virus status and pregnancy outcome 
was studied. The group of HIV infected mothers had a 75% higher risk of preterm 
delivery compared to HIV negative mothers. The risk of perinatal death in the HIV 
group was found to be 89% higher than the non infected-group.9 
A smaller prospective study performed in Kenya comparing perinatal outcome in a 
sero-positive group of mothers to a matched sero-negative group, found a 
significant increase in preterm birth in the sero-positive group [21% vs. 9.1%]. In 
addition, a small increase in perinatal mortality was found in the sero-positive 
group. On histopathologic examination of the placenta, a trend towards more 
chorio-amnionitis was found in the preterm group versus the term deliveries, this 
however was the same for both HIV positive and negative mothers.4 
An Indian group, Kumar et al, studying the impact of HIV-1 on pregnancy outcome 
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incidence of placental membrane inflammation (histological evidence of funicitis or 
chorio-amnionitis.)11in the HIV positive group. They concluded that HIV infection 
was associated with adverse maternal and foetal outcome.   
  
A large randomised controlled trial by Chi et al (Human Immunodeficiency 
Prevention Trials Network 024) attempted to lower the incidence of chorio 
amnionitis in a predominantly HIV infected cohort by prophylactic antibiotics.12 The 
findings were that antibiotic use did not have an effect on any of the outcome 
measures. There was no association found between stillbirth and HIV . Within the 
HIV positive group was found an inverse relationship between CD4 count and 
stillbirth rate. Univariate analysis of their data showed that the following factors 
were predictors of stillbirth: 
- Previous stillbirth 
- Antenatal haemorrhage 
- Clinical chorioamnionitis 
- Polymorphonuclear infiltration on placental histology.  
Birth weight of infants born to mothers infected with the HIV virus has been the 
subject of study by many investigators.  Bultereys et al found that maternal HIV-1 
infection was significantly associated with intra uterine growth restriction.13 Birth 
weight was also found to be significantly lower compared to the HIV negative 
group. Lambert et al found a 6% incidence of intra uterine growth restriction in 
babies born to an HIV positive mother in 2000.14   
Antenatal haemorrhage was found to be a risk factor for stillbirth in the cohort of 
mostly HIV positive mothers studied by Chi et al. 12   
A recent study conducted in Tshwane [South Africa] and published in the latest 
Perinatal Problem Identification Programme reports a similar trend in perinatal 
mortality rate as in the above literature (ref 10). The perinatal mortality rate in the 
group of mothers testing positive for HIV was found to be 40,5 per 1000 as opposed 
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pattern of primary obstetric cause of mortality between the two groups.7  The 
perinatal mortality rate per obstetric cause showed in the HIV positive group a 
trend toward preterm labour, infection and intrapartum asphyxia being the main 
causes of adverse outcome. In the HIV negative group hypertension was the main 
cause of perinatal mortality.  
In the Peninsula Maternal and Neonatal Service (PMNS) the impact of HIV on 
maternal mortality has been well documented; it would be of interest to investigate 
the impact of HIV infection on perinatal mortality in the PMNS.15  
     
DEFINITIONS. 
Stillbirth. 
The World Health Organisation has defined stillbirth as a foetal death late in 
pregnancy. 3 The gestational age when a miscarriage becomes a stillbirth is 
therefore left to the individual country policy as the gestation for foetal viability 
differs between developing and developed countries. For international comparison 
a stillbirth is defined as a loss after 22 weeks gestation or when gestation is 
unknown, death of a foetus weighing 500 grams or more without any signs of life at 
delivery. 
 
Early neonatal death.  
An early neonatal death is defined as the death of a live born infant weighing more 
than 500 grams at birth, within the first 7 days after birth. Moss et al report that 
more than two thirds of neonatal deaths occur within the first week of life.16  
Neonatal Encephalopathy. 
Neonatal encephalopathy is a clinical syndrome of disturbed neurologic function of 
the term and near term infant in the early neonatal period, manifested by 
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The disorder includes the condition hypoxic ischemic encephalopathy and is only 
called by this name if there is evidence that intra partum asphyxia is the cause of 
the encephalopathy. There has been a consensus statement by three bodies 
addressing the diagnosis of intrapartum asphyxia (American College of Obstetrics 
and Gynecology; American Academy of Pediatrics; International Cerebral Palsy Task 
Force.) The essential criteria for diagnosis:18 
-metabolic acidosis (pH <7,0) on umbilical artery blood gas 
- Apgar score of <3 at 5 minutes. 
-neonatal encephalopathy 
-cerebral palsy 
-exclusion of other causes of cerebral palsy. 
The severity of encephalopathy following the asphyxia is graded as per Sarnat 
score19 into mild, moderate and severe depending on clinical assessment.  
  
AIMS and OBJECTIVES: 
The aim of the proposed study was to determine the relationship between HIV 
infection and perinatal morbidity and mortality at Mowbray Maternal Hospital and 
catchment MOU’s. 
SPECIFIC OBJECTIVES: 
 1) To compare the Perinatal Mortality Rate in the group of HIV exposed with the 
HIV negative group and the untested group.                                                                 
 2) To determine where possible, the primary obstetric cause of poor outcome and 
compare this in HIV exposed to the HIV negative group and the untested group. 
3) To compare the incidence of Neonatal Encephalopathy in the group of HIV 





















Mowbray Maternity Hospital is a secondary obstetric unit serving a low to middle 
income urban population in Cape Town. Four primary Midwife obstetric run 
units(MOU’s) refer to Mowbray hospital. These include Gugulethu MOU, 
Khayelitsha MOU, Mitchell’s Plain MOU and Liesbeeck active birthing unit. 
The residential settlements in Cape Town are divided along geographical lines. Each 
of the mentioned MOUs serves all residents living in the suburbs in close proximity 
to the MOU. All pregnant women have access to free healthcare provided by the 
government of South Africa. As soon as the patient establishes that she is pregnant, 
she has the option of presenting to the particular MOU servicing her residential 
area in order to access antenatal care. The initial visit at the MOU is regarded as a 
screening opportunity and is commonly known as the “booking visit”. At this visit a 
qualified midwife will take a focussed history. The exercise is aimed at identifying 
risk factors in previous pregnancies or past medical history that may adversely 
affect the index pregnancy. Every MOU is supplied with a list of protocols 
identifying a range of risk factors in the history that would warrant the referral of 
the particular patient to the next level of care. A general physical examination and 
basic observations are done with the same objective. The only special investigations 
done at this visit include a blood test to ascertain the blood group and rhesus 
factor; serology to exclude syphilis and a rapid blood test for HIV. An overall risk 
based on the results of this visit is ascribed to the pregnancy and the patient then 
referred to the appropriate level of care. The Western Cape Department of Health 
have as official policy instituted Counselling and Voluntary testing of all pregnant 
mothers for HIV. Essentially this policy aims to counsel every pregnant mother with 
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counselled mother declines the test, she will then have an onsite rapid HIV test 
followed by a second confirmatory test if positive. The policy includes making 
available the antiretroviral drug, Zidovudine, to all seropositive mothers from 28 
weeks gestation as well as Nevirapine as single dose in labour. A blood test 
measuring the CD4 count is done on all seropositive mothers and those with a CD4 
count below 250 are referred for triple antiretroviral therapy. (Since the completion 
of this study the National Department of Health has increased the threshold for 
starting antiretroviral triple therapy to a CD4 count of 350). Treatment of the 
newborn to a seropositive mother is included in the treatment protocol. This is a 
compromise between cost and reducing antepartum and intrapartum vertical 
transmission of the virus. As counselling and voluntary testing for HIV infection is 
standard practice in the Western Cape, the HIV status is recorded in the clinical 
records for the majority of pregnant mothers.                                    
The perinatal auditing process at Mowbray Maternity Hospital and its referral 
MOUs is formal. All pregnancies with an adverse perinatal outcome; either stillbirth, 
early neonatal death or neonatal encephalopathy are reviewed. The process 
includes a detailed scrutiny of the clinical records pertaining to the index pregnancy 
by an assigned medical professional. The relevant information is recorded on a 
specially designed form (the perinatal audit form). At a monthly perinatal audit 
meeting attended by medical practitioners, nursing staff and administrative staff 
each case is discussed and an attempt made to identify any avoidable factors and 
the causes of adverse outcome. Placental histological examination assists in 
ascertaining the cause.  
 
STUDY POPULATION. 
This includes all women delivered at Mowbray Maternity Hospital and its referral 
MOUs between 01 January 2008 and 31 December 2008. 
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All deliveries born before arrival to any of the above institutions were excluded 




METHOD OF DATA COLLECTION: 
The study has, in an anonymous manner, reviewed all perinatal audit forms of 
patients recorded as having had perinatal mortality or Neonatal encephalopathy 
between January and December 2008.These forms provided basic demographic 
details, labour details and HIV status together with the assigned cause of death. 
Information was abstracted from these forms on to a purpose designed data 
collection sheet (appendix 1). In cases where perinatal audit forms had not yet been 
completed the medical records were retrieved and data abstracted from those 
records.    
The Western Cape Department of Health make use of Cradle software to record all 
delivery details .These records were reviewed in order to quantify the total number 
of deliveries at Mowbray Maternity Hospital between January 2008 and December 
2008.The HIV registers at Mowbray Hospital were consulted in order to quantify the 
number of deliveries to mothers with an HIV status recorded as positive. The HIV 
untested sample was quantified by consulting the voluntary counselling and testing 
(VCT) records for Mowbray Hospital (MMH) and MOUs. These records had recorded 
the number of patients who declined a voluntary test for HIV during the course of 
their antenatal care. A number of patients had an untested status by virtue of non 
attendance of any form of antenatal care (either in private health care or in failing 
to access antenatal care in any other part of the country eg. Eastern Cape Province). 
The records of the admission suite at Mowbray Hospital were manually searched 
and identified patients attending MMH with an “unbooked” status. These numbers 
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The number of deliveries at the catchment midwife run obstetric units was accessed 
via the PIPP (Perinatal Problem Identification Program). Perinatal mortality data was 
also accessed via this system. Voluntary counselling and testing data was requested 
from the central province health offices where all MOU’s send their monthly 
statistics to. The number of deliveries to HIV positive mothers was recorded in this 
data as well as the number of deliveries to untested mothers.  
DATA COLLECTION FORMS.  




4) results of antenatal syphilis test in patients booked for antenatal care, 
5) result of HIV test in patients booked for antenatal care and accepting voluntary 
counselling and testing(VCT). 
6) booking status. 
Delivery data recorded included: 
1) mode of delivery, 
2) birth weight at delivery, 
3) gestational age at delivery, 





















Data was collected using a hand search of clinical records. Data was recorded on a 
purpose designed data extraction form [Microsoft Excel format]. 
Descriptive data was analysed using Microsoft Excel statistical. 
Detailed statistical analysis was done using the Graphware Prism 3.0 software 
program. 
Frequency data was compared using a standard two by two table. Fisher’s exact 
test, Chi squared tests  and odd ratios were calculated. 
Demographic data was compared using unpaired Kruskal-Wallis test and one way 
ANOVA tests. 
ETHICS. 
Since this is an obstetric audit, it has general ethical permission from the ethics 
committee of the University of Cape Town. However, the proposal was submitted 
to this committee for ratification. Ethics approval was granted by the UCT ethics 
committee (REC.REF 282/2010 –see Appendix). 
























There were a total of 18,870 deliveries at MMH and its catchment MOUs during 
2008. There were 379 perinatal deaths combined for the 4 delivering units being 
studied. The combined perinatal mortality rate for the whole population was 
therefore 20.1 per 1000 deliveries. 
Table 1.Number of deliveries by HIV status at Mowbray Maternity 
Hospital and referral MOUs. 


















547 (5,8%) 9338 
Mitchells 
Plein MOU 
368 (8,7%) 3235 
(77,1%) 
589 (14%) 4192 
Khayelitsha 
MOU 
659 (25,8%) 1678 
(65,7%) 
216 (8,4%) 2553 
Guguletu 
MOU 
485 (17,4%) 2011 
(72,1%) 
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Delivery statistics at MMH. 
During the year January 2008 to December 2008 there were 9338 deliveries at 
MMH. Of these, 1774 were deliveries to mothers who tested positive for HIV; the 
rate of deliveries to HIV seropositive mothers was therefore 18,7%. 
The number of mothers with an untested HIV status was 547; this was the sum of 
126 mothers who were “unbooked” for antenatal care and went on to deliver 
without the opportunity of having  an HIV test, plus 421 mothers who declined an 
HIV test throughout their antenatal care. The rate of untested mothers was 5,8%. 
The total of deliveries to HIV negative women was 7044(75,4% of the total delivered 
population at MMH). 
  
Delivery statistics at MOUs. 
Guguletu MOU. 
The total number of deliveries at Guguletu MOU for 2008 was 2787. 
The number of deliveries to seropositive mothers was 485. This translates to 17,4% 
of the total number of deliveries at the MOU. 
The number of mothers delivering without an HIV test having been done was 291 
(10,4% of the total number of deliveries). 
The number of deliveries to HIV negative mothers was 2011(72,1%). 
Mitchell’s Plain MOU. 
The total number of deliveries at MPMOU for 2008 was 4192. 
The number of deliveries to HIV positive mothers totalled 368 with a percentage of 
8,7%. 
The number of untested mothers delivering at MPMOU totalled 589 with a 
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Khayelitsha MOU.  
There were 2553 deliveries at KMOU during 2008. Of these 659 deliveries were to 
HIV positive mothers, this is 25.8% of the total number of deliveries. 
The number of  untested mothers at KMOU for 2008 was 216 (8,4%). 
Combined data.  
The number of deliveries at the four units combined for 2008 totalled 18 870. The 
combined number of deliveries to HIV positive mothers was 3259 (17,2%). 13 968 
deliveries were to mothers testing negative for HIV(74%). There were 1643 
deliveries to mothers with an untested status at a percentage of 8,7%. 



















No. SB’s  
(Rates) 




No. SB’s  
(Rates) 
  Rates 
 +ve 
 
8   (16,4)  
 
3    (8,1)  2   (3,0)  43   (24,6)  
 






13   (6,4) 
 
12   (3,7)  
 
11  (6,5)  
 






26  (89,3)  
 
26    (44,1)  
 
23 (106,4)  
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*Comparing HIV positive to HIV negative groups. 
*All rates = number of stillbirths per 1000 total births. 
 
GUGULETU MOU. 
The stillbirth rate in the HIV positive group of mothers at Guguletu MOU was 16,4 
per 1000 deliveries. This rate was 6,4 per 1000 in the HIV negative group of 
mothers. Those without an HIV test had a stillbirth rate of 89,3 per 1000. 
Mitchells Plain MOU.  
The stillbirth rate at Mitchells Plain MOU in the HIV positive group was 8,1 per 1000. 
In the HIV negative group this rate was 3,7 per 1000. Those mothers without an HIV 
test had a rate of 44,1 per 1000. 
KHAYELITSHA MOU. 
The stillbirth rate at KMOU in the group of HIV positive mothers was 3,0 per 1000 
deliveries. The rate in the HIV negative group was 6,5 per 1000 deliveries. Those 
mothers without an HIV test had a stillbirth rate of 106,4 per 1000. 
 
Mowbray Maternity Hospital. 
The stillbirth rate at the referral centre for these primary MOUs was  24,6 per 1000 
in the HIV positive group of mothers. For the HIV negative group this rate was 11,4 
per 1000. In the untested group the rate was 95 per 1000 deliveries. 
COMBINED STILLBIRTH RATES. 
Combining the data from all the units being studied showed a combined stillbirth 
rate of 17,1  per 1000 in the HIV positive group of mothers. The rate in the HIV 
negative group was 8,3 per 1000 deliveries. Statistical analysis comparing the HIV 
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confidence interval, 1,5-2,8) The calculated P-value was <0,0001. This was 
statistically significant. In the untested group this rate was 77,2 per 1000.   
  
 
Comparison of early neonatal death rate by HIV status. 
Table 3.  






















ENND’s   
(Rate) 
No.  
ENND’s   
(Rate) 
 +ve  2  (4,1)  
 




 -ve  3   (1,4) 0 
(0) 
3   (1,7) 11   (5,3) (3,1) 
 untested 
 
1   (3,4) 6   (10,1) 3   (13,8) 10   
(12,7) 
(10,3)   
*Comparing HIV positive to HIV negative group. 


















The neonatal death rate at Khayelitsha MOU  born to mothers with a positive HIV 
status was 1,5 per 1000.The rate in the group of seronegative mothers was 1,7 per 
1000.The  untested group had a rate of 13,8 per 1000. 
 
 
Guguletu MOU.  
The neonatal death rate in the HIV positive group was 4,1 per 1000 deliveries. Their 
negative counterparts had a rate of 1,4 per 1000 deliveries. The untested group had 
a neonatal death rate of 3,4 per 1000. 
Mitchell’s Plain Mou.  
The neonatal death rate in the HIV positive group at Mitchell’s Plain MOU was 2,7 
per 1000 deliveries. The untested group had a rate of 10,1 per 1000. 
Mowbray Maternity Hospital.  
The neonatal death rate in the HIV positive group of mothers delivered at MMH was 
6,2 per 1000 deliveries. The corresponding rate in the HIV negative group was 5,3 
per 1000. The untested group had a rate of 12,7 per 1000. 
Combined neonatal death rates.  
The combined neonatal death rate for the five units being studied : HIV positive 
group 4,6 per 1000 deliveries. In the HIV negative group the combined rate was 3,1 
per 1000. In the untested group this rate was found to be 10,3 per 1000. Statistical 
analysis suggested an odds ration of 1,46 when comparing the HIV positive with the 
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Comparison of perinatal mortality rate by HIV status for the combined 
study population. 
Table 4. 
















































*Comparing HIV positive to HIV negative group. 
The combined perinatal mortality rate in the HIV positive population at the units 
being studied was 21,7 per 1000 deliveries. The corresponding rate in the HIV 
negative population was 11,5 per 1000 deliveries. Statistical analysis performed 
comparing the HIV negative and positive groups with regards to perinatal mortality 
found an odds ratio of 1,91 (95% confidence interval 1,4-2,5) The calculated  p-
value was  <0,0001. The perinatal mortality rate in the  untested group was 87,6 per 








































34 per 1000 
(56) 









5,4 per 1000 
(9) 









4,8 per 1000 
(8) 









2,4 per 1000 
(4) 
















































4,8 per 1000 
(8) 










3,6 per 1000 
(6) 














In the HIV positive population preterm labour was responsible for 4,2 per 1000 
deaths. In the HIV negative group this rate was found to be 3,0 per 1000. In the 
untested group 34 per 1000 deliveries were caused primarily by prematurity. The 
calculated odds ratio was 1,3. The calculated  p-value was  0,35. 
Infection. 
Infection was the primary cause of death in 5,2 per 1000 deliveries in the HIV 
exposed group. In the corresponding HIV negative group 1,2 per 1000 deliveries 
were caused primarily by infection. This rate was 5,4 per 1000 in the untested group 
of patients. The odds ratio calculated was 4,3 comparing HIV positive and HIV 
negative populations( 95% confidence interval between 2,19 and 8,4). The 
calculated  p-value was <0,0001. In the majority of cases, i.e 79,8%, placental 


















Asphyxia was the cause of death in 3,3 per 1000 deliveries in the HIV positive group. 
In the HIV negative group it caused mortality in 1,8 per 1000 deliveries. In the 
untested group this rate was 4,8 per 1000. The odds ratio worked out as 1,8 with a 
p-value of 0,14. 
Intra uterine growth restriction.  
IUGR was found to result in mortality in 3,0 per 1000 deliveries in the HIV exposed 
group as opposed to 0,6 per 1000 deliveries in the HIV negative group. In the 
untested group this rate was 2,4 per 1000 deliveries. The odds ratio comparing HIV 
positive to HIV negative groups was 4,7 (95% confidence interval 1,93-11,7)with a p-
value of 0,0005. 
Antepartum haemorrhage.  
Antepartum haemorrhage caused mortality in 3,6 per 1000 deliveries in the HIV 
positive group as opposed to 1,2 per 1000 in the HIV negative population. In the 
untested group it was found responsible in 12,1 per 1000 deliveries. The odds ratio 
was 2,8 (95% confidence interval between 1,37 – 5,,93).The p-value was 0,006. 
 
Unexplained.  
Unexplained death was coded as primary obstetric cause of mortality  in 2,7 per 
1000 deliveries in the HIV positive group compared to 1,8 per 1000 in the negative 
group. 13,9 per 1000 deliveries in the untested group were due to unexplained 





















In the HIV positive group 0,3 per 1000 deliveries ended with mortality due to 
hypertension as opposed to 0,5 per 1000 deliveries in the HIV negative group. In the 
untested group this rate was 4,8 per 1000 deliveries. The odds ratio was 0,5 with a 
p-value of 0,86. 
Congenital abnormality.   
In the HIV exposed group this caused mortality in 0,6 per 1000 deliveries as 
opposed to 0,5 per 1000 in the HIV negative group. The untested group had a rate 
of 3,6 per 1000. The odds ratio calculated was 1,2 with a p-value of 0,86.  
 
 
DEMOGRAPHIC DATA.  
Comparison of demographics by HIV status in the group of mothers 
with stillbirth.  
(Table 6) 











27,9[5,9] 25,9[5,4] 24,9[6,1] 0.076[n/s] 
Birth weight 
(median)  
 1400g  2010g  1040g 0.678[n/s] 


















(median)    
 2 2 11  
Parity (median)        1 1 0  
% patients CD4 
count < 350  
 
35,4% 
N/A N/A  
% patients CD4 
count <200 
12,9%    
*Comparison between HIV +ve and HIV –ve groups. 
Table 6 compares the results and statistical analysis of demographic data in the 
group of mothers with a stillbirth. The p-value is calculated comparing the HIV 
exposed to the HIV negative group. 
 
Maternal age.  
The mean maternal age in the HIV exposed group was 27,9 with a standard 
deviation of 5,9 years. This opposed to a mean age of 25,9 and a standard deviation 
of 5,4 in the HIV negative group. The untested group had a mean age of 24,9 and 
standard deviation of 6,1 years. Comparison between HIV exposed and negative 
groups showed a non-significant difference and a p-value of 0,076. 
Birth weight.   
The mean birth weight in the HIV positive group was 1867,5 grams with a standard 
deviation of 895,7 grams. In the HIV negative group the mean birth weight was 
1941,6 grams with a standard deviation of 1006,7 grams. The mean birth weight in 
the untested group was found to be 1541,1 grams with the standard deviation 
being 976,5 grams. There was no significant difference in birth weight comparing 

















The mean gestational age at delivery in the HIV exposed population was 31,8 weeks 
with a standard deviation of 5,3 weeks. In the HIV negative group the gestational 
age at delivery was 32,5 weeks and the standard deviation was 5,7 weeks. The 
untested group of patients delivered on average at 29,3 weeks of gestation with a 
standard deviation of 5,4 weeks. A comparison between HIV positive and negative 
groups showed a non-significant difference with a p-value of 0,525. 
Gravidity and parity. 
The mean gravidity and parity in the HIV exposed group was 2,2 and 1,2 
respectively (standard deviations were 1,1 and 1,0 respectively). In the HIV negative 
group the means were 2,1 and 1,0 respectively, the standard deviations were 1,3 
for both gravidity and parity. In the untested group the mean values were 1,8 and 
0,7 respectively. The standard deviations were calculated as 1,1 and 1,0.     
CD 4 cell count.  
The average lymphocyte cell count displaying CD 4 surface marker was 423,9.The 
maximum count was found to be 1320 and the minimum 129.The CD 4 count was 
documented for 67,3% of cases.  
Comparison of demographic data by HIV status in group of mothers 
with neonatal death.  
(Table 7)  
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2 2 3  
Parity 
(median) 
1 1  3  
*Comparison between HIV +ve and HIV –ve groups.  
Table 7 compares the demographic data for mothers with an early neonatal death. 
The calculated p-value compares the HIV exposed to the HIV negative group. 
Maternal age. 
The mean maternal age for the group testing positive for HIV was 27,2 years with 
the standard deviation 2,8 years. In the HIV negative group the mean age was 26,2 
and the standard deviation 5,9 years. The untested group had the youngest average 
age of 25,2 years with a standard deviation of 6,7 years. A comparison between the 
HIV exposed and negative groups showed a non-significant difference with a p-
value of 0,362. 
Birth weight. 
The mean birth weight in the group of HIV positive mothers was 1277 grams with 
the standard deviation 905,9 grams. The mean birth weight in the HIV negative 
group was 1641,3 grams with a standard deviation of 1054 grams. In the untested 
group the average weight at birth was 1222,6 grams with a standard deviation of 
562,6 grams. A comparison the HIV positive and negative groups showed a non-
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Gravidity and parity.   
The average gravidity and parity in the HIV exposed group were 3,06 and 1,9 
respectively; the standard deviations were 1,4 and 1,5 respectively. In the HIV 
negative group these averages were 2,0 and 1,0 with standard deviations of 1,0 and 
0,9. The averages in the untested group were 2,4 and 1,4 respectively with standard 
deviations of 1,3 and 1,2 respectively.   
NEONATAL ENCEPHALOPATHY. 
Comparison of neonatal encephalopathy rate by HIV status and 
demographic data in this group of parturients. 
Table 8. 
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with CD4 <350 
% of patients 
with CD4 <200 
 
40% 
N/A N/A   
*Comparing HIV +ve to HIV –ve groups. 
Table 8 shows the comparison of the rate of neonatal encephalopathy by HIV status 
as well as the comparison of demographic data by HIV status of mothers with a 
neonate diagnosed with neonatal encephalopathy. 
Neonatal encephalopathy rate by HIV status.  
The rate of neonatal encephalopathy in the group of HIV positive parturients was 
4,9 per 1000 deliveries. The rate in the group of HIV negative mothers was 2,07 per 
1000 deliveries. In the untested group this rate was calculated as 4,86 per 1000 
deliveries. Analysing the difference between the HIV positive and negative groups 
statistically showed a significant difference. The odds ratio was 2,36 with the 95% 





The average maternal age in the HIV positive population was 25,4 years with a 
standard deviation of 4,6 years. In the HIV negative population the mean age was 
23 years and the standard deviation calculated was 6,2 years. Mean age in the 
untested group of mothers was 26,8 years with a standard deviation of 7,0 years. A 
comparison between the HIV positive and negative groups was statistically non-
significant. The calculated p-value was 0,154. 
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The average gestational age at birth in the HIV positive group was 37 weeks with a 
standard deviation of 2,7 weeks. In the HIV negative group the mean gestational 
age at delivery was 37,3 weeks with the standard deviation being 4,2 weeks. The 
mean gestation in the untested group was 38,4 weeks and the standard deviation 
2,5 weeks. A comparison between HIV positive and negative groups calculated a 
non-significant p-value of 0,882. 
Birth weight. 
The average birth weight in the HIV positive group was 2923 gram with a standard 
deviation of 732 gram. In the HIV negative group the mean weight at birth was 2957 
gram with the standard deviation 770,5 gram. The corresponding values for the 
untested group was 3140 gram and SD 484,1 gram. The calculated p-value was non-
significant at 0,738. 
CD 4 count. 
The average CD 4 count for individuals in the group of mothers with a neonatal 


























The study shows that there is a statistically significant difference in the perinatal 
mortality rate between the group of parturients exposed to the Human Immune 
Deficiency virus and their non-exposed counterparts in the population being 
studied. This is due to a significantly higher stillbirth rate in the HIV positive group 
as there was found to be no difference in the neonatal death rate between the two 
groups as opposed to the significantly higher neonatal death rate(odds ratio 3,61[CI, 
1.76-7.44]) found in the Tshwane study. 7 The lack of significant difference between 
the HIV positive and negative groups with regards to neonatal death rate could be 
due to the high standard of neonatal care at the hospital. The data also indicates no 
significant differences in demographic factors and birth weight between HIV 
exposed and negative groups thus excluding these as possible confounding factors 
for the study findings. 
This finding is in keeping with many other published studies including the study 
done in Tshwane in 2006.4,7  These studies were done in resource limited countries 
but the results were confirmed by a study done by Ellis et al in a large inner city 
hospital in Atlanta, USA also commenting in the conclusion that a sero positive 
mother was “more lik ly to have a perinatal death”.20   
Another differe ce between this study and the Tshwane study was the pattern of 
primary obstetric cause of mortality. The study in Tshwane found that preterm 
labour and infection were significantly more common as a cause for perinatal 
mortality in the HIV positive group compared to their negative counterparts. The 
Mowbray and referring MOU experience was that infection (i.e chorioamnionitis), 
intra-uterine growth restriction and ante partum haemorrhage was significantly 
more common in the HIV group.  
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This preponderance to chorioamnionitis in an HIV exposed group as a cause for 
adverse perinatal outcome has been documented in several other studies.7,11 One 
possible theory explaining this trend toward higher incidence of intra uterine 
infection in an HIV exposed group is the immune suppression caused by the virus 
leading to ascending infection of membranes and eventually liquor. However the 
HPTN 024 study by Goldenberg et al analysing the impact of random antibiotics on 
histological evidence of chorioamnionitis concluded that antibiotic use was not 
associated with a reduction in histological evidence of chorioamnionitis when a 
nevirapine anti-retroviral regimen was used.21 The Goldenberg study reported on 
the same cohort in Zambia,Tanzania and Malawi as analysed by Chi et al. This is an 
important negative finding as it may have been thought possible to reduce the 
adverse perinatal outcome due to chorioamnionitis in the HIV positive group by 
prescribing prophylactic antibiotics in labour.  
The significantly higher rate of perinatal mortality caused by IUGR in the HIV 
positive group of patients has been documented in previously conducted studies. 
Interpretation of this finding is difficult due to most studies having been done in 
developing countries and confounding factors like poor nutrition and advanced 
maternal disease have often been blamed for IUGR. 9,22 The prospective study in 
Nairobi, Kenya found no increased risk of IUGR in the HIV positive group compared 
to their negative counterparts.4 A more recent study by Iqbal et al found a 
relationship between CD 4 count and IUGR in a group of HIV infected mothers, the 
lower the CD 4 count the higher the risk of IUGR.23 Stratification of the HIV exposed 
group of patients with regards to CD4 count and the effect it has on IUGR and 
outcome could be a basis for future study.  
It is difficult to explain the finding that antepartum haemorrhage was significantly 
more common as of obstetric cause for adverse perinatal outcome in the HIV 
positive population. This finding is also reported in the large cohort in the HPTN 024 
trial.21  
The different trend in perinatal mortality rate at the Khayelitsha MOU is also 
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other MOUs. During the data collection phase of the study the impression was that 
record keeping at Khayelitsha MOU was not of the same standard as the other 
units. It is thus possible that the differing trend could be the result of inaccurate 
data from records. However, as the trend at KMOU was the opposite to that at the 
other units it cannot diminish the significance of the overall results in this study. On 
the contrary if data at KMOU were more accurate and mirrored the trend at the 
other units it would emphasize the combined trend.   
 
NEONATAL ENCEPHALOPATHY.   
The increased risk of neonatal encephalopathy in the HIV exposed parturients could 
be due to the immune suppression caused by the virus resulting in higher rates of 
clinical and subclinical intra uterine infection. The foetus exposed to this 
environment has a much lower capacity to tolerate the stress of labour without 
becoming acidotic and suffering the consequences thereof.24 Several studies have 





The results indicate that the group of patients without an HIV test during the 
pregnancy is at much higher risk of perinatal mortality and morbidity than the other 
two groups. The untested group consists mainly of a group of patients who were 
“unbooked” at any medical institution for antenatal care. Several studies have 
confirmed that a lack of ante natal care is an independent risk factor for adverse 
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LIMITATIONS AND STRENGTHS OF THE STUDY. 
A limitation of the study was the fact that it was a retrospective study. In addition 
the lack of adequate record keeping limited the analysis that could be performed on 
data in the HIV positive population. Only 69% of patients had a CD 4 count 
recorded. This lack of complete data was due to incomplete record keeping thus 
limiting the ability to explore an inverse relationship between CD4 count and 
stillbirth.   
It was not possible to collect data regarding smoking history during the pregnancy 
and its impact as a confounding factor on perinatal outcome is therefore unknown. 
IMPLICATIONS OF THE STUDY. 
Interpretation of the results of this study indicates that early detection and 
treatment of HIV in pregnant mothers to prevent the complications of immune 
suppression would reduce perinatal morbidity and mortality in this at risk group. 
Maintaining a higher CD4 and a low as possible viral load in these patients should be 
the goal of antiviral therapy from as early as possible in pregnancy. In an ideal 
situation this group should have access to prenatal clinics in order to assist in 
achieving this goal. 
A concerted effort by Government to educate the community regarding the dire 
effect of a lack of ante natal care on pregnancy outcome should be made.  
 
CONCLUSION. 
The risk of stillbirth is higher in an HIV exposed population compared to their HIV 
negative counterparts. Infection, IUGR and ante partum haemorrhage is more 
common as an obstetric cause for mortality in the HIV positive group. 
The untested group of patients in this study was found to be at much higher risk of 
adverse pregnancy outcome than both HIV positive and HIV negative patients.   


















    
APPENDICES. 
A} Data collection sheet. 
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